Trasylol - Study Finds Risk of Kidney Failure, Heart Attack & Stroke January 26, 2006 - A study published in the New England Journal of Medicine ("NEJM") found that Trasylol (aka "Aprotinin") doubles the risk of kidney damage, which it is estimated, could force approximately 10,000 patients onto dialysis each year. The study of about 4,400 patients also reported that Trasylol was found to increase the risk of heart attack by 48%, heart failure by 109% and stroke by 181%. The researchers concluded that the drug was not even necessary in most cases because there were two generic drugs that cost a tenth as much and were nearly as good at stopping bleeding yet produced no increased risk. If you know, or suspect, you were given the drug Trasylol during your heart surgery and later were diagnosed with one of the following complications: - Kidney damage resulting in the need for dialysis;
- Heart attack or
- Stroke
Please call us for a free consultation at our toll-free number: (800)351-8588 or click here to send us an e-mail and someone from our law firm will get in touch with you. Link to FDA Advisory - 2/8/06 Link to NEJM abstract
|
